Elevated Fatty Acid Binding Protein 4 (FABP4) Associated With Liver Damage and Kidney Complications in Thalassemia Patients.

Experience of Prenatal Diagnosis for β-Thalassemia and Major Hemoglobinopathies in the Last Decade from Seven Tertiary-Care Referral Centers in India.

A dual-modal machine learning framework integrating red blood indices and smartphone-captured microscopic images for β-thalassemia screening.

HbS-β thalassemia mimicking HbSS on DdeI RFLP: Report of a pitfall circumventable by Sanger sequencing and parental testing.

Compound Heterozygous Hemoglobin E-Beta (HbE-β)-Thalassemia Presenting With Chipmunk or Rodent Facies, and a Severe Thalassemia Major Phenotype.

Multimodal evidence chain of iron overload, inflammation, and dysfunction: an integrated predictive model of early cardiac injury in pediatric transfusion-dependent β-thalassemia.

Patient-Reported Outcomes With Luspatercept Through 5 Years of Treatment in Patients With Non-Transfusion-Dependent β-Thalassemia Treated in the BEYOND Trial.

Clinical integration of red cell genotyping in children with β-thalassemia major: a prospective observational study.

Vamifeport, a clinical stage oral ferroportin inhibitor, alleviates murine lupus nephritis: A pilot study.

Genetics and Genomics in Sickle Cell Disease in Africa.

From Iron Deficiency to Overload: A Missing Link in the Mechanisms of Cardiac Autonomic Nervous System Dysfunction.

Regulation of BCL11A DNA binding and expression in human erythrocyte precursor HUDEP-2 cells.

Clinical and Hematological Characteristics of Vietnamese Heterozygous Hb Tak/β-Thalassemia Patients: A Four-Case Series.

Association Between Iron Overload and Glucose Metabolism in Children and Youth with Transfusion-Dependent Beta Thalassemia: The Role of Chelation Therapy.

CRISPR in Medicine: A Systematic Review of Clinical Trials and Therapeutic Applications.

Comparative Analysis of Erythroferrone and Hepcidin as Emerging Biomarkers of Iron Homeostasis in Patients with β-Thalassemia Major: A Case-Control Study from Pakistan.

Diagnostic accuracy of hematological indices and logistic regression for β-thalassemia carrier screening in children.

Circ_0001428 regulates erythropoiesis and γ-globin expression via activating the ATF4-BCL11A axis in β-thalassemia.

CRISPR in Thalassemia: Global Research Trend Analysis.

Clinico-epidemiological Profile of Transfusion-dependent Thalassemia Patients in a Tertiary Care Children's Hospital in Nepal: An Observational Study.

Genetic variations and clinical implications of B-thalassemia in Iraqi population.

Red Blood Cell Metabolomic Signatures in β-Thalassemia Heterozygotes With Elevated HbA1c: Implications for Biomarkers and Personalized Medicine.

Darbepoetin therapy for anaemia and orthostatic presyncope and palpitations in a woman with beta-thalassemia minor and possible postural orthostatic tachycardia syndrome.

Current Status of Clinical Gene Therapy for Hemophilia and Globin Disorders.

First Case of Hb City of Hope (HBB: c.208G > A) in Andalusia. A Molecular Update of β-Thalassemia in Southwestern Spain (Huelva Province).

Management of CMV Pneumonia, DAH, and BOS Following HSCT in a Child with β-Thalassemia: A Case Report.

A novel HBD gene mutation associated with normal-range hb A2 in β-thalassemia carriers.

Utility of First-Line Diagnostic Tests and Molecular Methods for Accurate Characterization of Sickle Cell Disorders.

Behind the splenomegaly: a parasitic twist in siblings with beta thalassemia trait.

A Multifactorial Presentation of Infection and Thrombosis: Temporal Clustering of Pneumonia, Hepatic Abscess, Bilateral Deep Vein Thromboses (DVTs), and Appendicitis in a Child.

Reproductive Endocrine Stability Despite Persistent Hypogonadism in Well-Chelated Adult Women with Transfusion-Dependent β-Thalassemia.

Curative Approach to the Treatment of Beta-Thalassemia and Sickle Cell Disease with Hematopoietic Stem Cell Transplantation.

Systematic Review of Non-Coding Genomic Variants in Globin and Non-Globin Clusters and Their Impact on Phenotypic Severity in Thalassemia and Sickle Cell Disease.

Therapeutic Potential of Deferiprone-Resveratrol Hybrid (DFP-RVT) Against Hepatic Iron Overload in β-Thalassemia Mice: A Proteomic Analysis.

Emerging Considerations in Transfusion Medicine: Hematopoietic Stem and Progenitor Cell Collection for Gene Therapy for Sickle Cell Disease and Transfusion-Dependent Thalassemia.

An Integrated Genotyping Strategy for α/β-Thalassemia: Based on the Analysis of the Coding Sequences and Expression Levels of HBA2, HBA1, and HBB in Peripheral Blood mRNA.

Difficult Cases in the Diagnosis of Thalassemia Syndromes.

Vitamin B12 Deficiency Does Not Induce Homocysteine Increase in Transfusion-Dependent β-Thalassemia Major Patients Receiving Folic Acid Supplementation.

Pulmonary hypertension in beta thalassemia: a prospective cohort study on treatment outcomes and cardiopulmonary function.

Impact of Beta-Thalassemia Trait on Clinical Outcomes and Treatment Response in Chronic Myeloid Leukemia.

Molecular Genetics and Recent Management Strategies of HB E-β Thalassemia.

Synergistic Potential of Thalidomide and Hydroxyurea in Sickle Cell Disease Management: A Promising Combination Therapy.

How I manage luspatercept in transfusion-dependent beta-thalassemia.

Prediction of β-thalassemia carrier using federated learning and explainable AI.

When HbA1c looks "too high": two practical clarifications for endocrine screening in chelated β-thalassemia major.

Safety and efficacy of hemobeglogene autotemcel(hemo-cel) gene therapy in five patients with transfusion-dependent β-thalassemia.

MLDP-AS: an optimized next-generation sequencing assay for enhanced detection of technically challenging variants in expanded carrier screening.

Machine learning and AI-Assisted red blood cell morphology analysis for effective thalassemia screening.

Endothelial dysfunction and cardiac damage indicators in patients with β-thalassemia major under iron-chelation therapy.

miRNA-Mediated Regulation of γ-Globin to β-Globin Switching: Therapeutic Potential in β-Hemoglobinopathies.

Comprehensive expression of long non-coding RNAs and association with iron and erythropoiesis regulatory proteins in transfusion-dependent β-thalassemia.

Assessing Cardiac Mechanical Dysfunction in Transfusion-Dependent β-Thalassemia With History of Atrial Fibrillation: The Role of Speckle Tracking Echocardiography.

Beta-Thalassemia Major Complicated by Streptococcal Toxic Shock Syndrome: A Rare Case of Survival and Successful Management.

Mesangial sclerosing glomerulopathy following luspatercept treatment - a case report.

Overcoming transfusion-refractory anemia: partial splenic embolization to facilitate orthopedic surgery in β-thalassemia.

Therapeutic potential of polyphenols in managing thalassemia: A comprehensive review.

[Genetic screening and typing study of Thalassemia among ethnic Miao Group in Qianxinan area of China].

Impact of iron chelation therapy on thyroid function in beta-thalassemia major patients from Pakistan.

Subtype Distribution and Mutation Spectrum of Thalassemia in Children Under 10 Years in Northern Vietnam.

End-of-Life Care in Sickle Cell Disease and Transfusion-Dependent β-Thalassemia: Clinical, Psychosocial, and Ethical Considerations.

Voluntary thalassemia screening: behaviours and constructs among youths from a thalassemia hot spot in Sri Lanka.

Red blood cell alloimmunization in transfusion-dependent β-thalassemia major patients in Eastern Iran.

The impact of the expression signatures of LncRNAs HBBP1 and XIST on the diagnostic significance of patients with β-Thalassemia.

Many faces of non‑deletional α‑thalassaemia variants in neonate and early childhood.

A Case Report of HLA 5/10 Cord Blood Cell Engraftment in a Patient with Severe β Thalassemia after Haplo-Cord Stem Cell Transplantation.

Alterations in Serum MAO Activity and Tau Levels in β-Thalassemia.

Economic burden of non-transfusion-dependent thalassemia in the United States.

Functional correction and genome integrity with duplex base editing of β-thalassemic hematopoietic stem cells.

Adult survivors of sickle cell disease, transfusion-dependent beta-thalassaemia and childhood acute leukaemia in England: protocol for a mixed methods data linkage and health-related quality of life survey study.

UGT1A6 variants and deferiprone-induced ADRs: a complication-specific analysis in Iranian thalassemia patients.

Detection of β-Thalassemia Mutations in Term Neonates with HbA ≤15% Using Capillary Electrophoresis and Molecular Analysis.

Altered cerebral morphometry and individual-based morphological brain network in children with beta-thalassaemia major.

Beyond the Exome: The Role of Noncoding and Regulatory Variants in Monogenic Diseases.

Interpretable machine learning models for beta thalassemia prediction: an explainable AI approach for smart healthcare 5.0.

Prevalence of Severe Thalassemia and Performance of Prenatal Screening Tests Among Pregnant Women at Siriraj Thalassemia Center in Thailand.

Effect of Epigallocatechin-3-Gallate on Depression-Related Cytokines in Thalassemia Patients: Molecular and Cellular Evaluation.

Association of CYP2C19 gene single nucleotide polymorphisms (rs12248560 and rs4244285) with response to thalidomide in transfusion dependent β-thalassemia patients- a 12-months follow-up study.

Taurine intake ameliorates lactic acidosis and hyperferritinemia occurring after mRNA SARS-CoV-2 vaccination in a patient with β-thalassemia trait: a case report and review of literature.

Two Novel SUPT5H Variants Causing β-Thalassemia Trait Phenotypes.

Functional Abnormalities of the Endocrine System in Beta-Thalassemia Major Patients: Insights From a Hospital-Based Observational Study.

Adaptation of lentiviral vectors for viral gene therapy and their impact on host cell biology.

Vaso-Occlusive Thrombotic Ischemic Colitis Presenting With Large-Volume Hematochezia in Sickle Cell Beta+-Thalassemia.

Quantification of Myocardial Iron and Fat - An Experimental Study with Photon-Counting Detector CT.

Erythropoiesis in health and disease: Distinguishing defective and ineffective erythropoiesis.

Atrial fibrillation prevalence and its management in aging transfusion-dependent thalassemia patients: the FATHAL study.

Case series: a rare dominant form of β-thalassemia successfully treated by luspatercept.

First Report of Hb Oslo [HBB:c.127T>A; β42(CD1)Phe→Ile] from India and its Novel Compound Heterozygous Combination with IVS1-5 G>C [HBB:c.92+ 5G> C] Leading To β-Thalassemia Major.

Enhanced induction of fetal hemoglobin by the combination of decitabine with RN-1 in β-thalassemia/HbE erythroid progenitor cells.

HbE/β-thalassemia presenting with Moyamoya angiopathy-associated ischemic stroke and noncompressive intrathoracic extramedullary hematopoiesis.

T1 mapping and speckle tracking echocardiography for the assessment of early mechanical dysfunction in transfusion-dependent β-thalassemia with normal T2.

[Epidemiological, clinical, angiographic and therapeutic features of sickle cell retinopathy in Burkina Faso].

Adult-Onset β-Thalassemia Major as Acquired Imprinting Disorder.

Nanopore long-read sequencing reveals a novel 3.4-kb HBB deletion causing β-thalassemia in prenatal diagnosis: a case report.

Establishing hemoglobin A, F, A2 reference intervals in neonatal cord blood and clinical decision values for β-thalassemia genetic testing.

Long-term efficacy and safety results of betibeglogene autotemcel gene therapy for transfusion-dependent β-thalassemia.

Effect of Closed Kinetic Chain Exercise Via Telerehabilitation on Muscle Strength, Balance, Fatigue and Hemoglobin Levels in Beta Thalassemia Major Children: A Randomized Controlled Trial.

Role of Serum Apelin and Carotid Artery Intima Thickness in Predicting Early Atherosclerotic Changes in Children With Beta-Thalassemia Major.

Genetic patterns & public health implications of sickle cell anaemia across populations: A systematic review.

Ineffective Erythropoiesis Markers in β-Thalassemia: A Systematic Review.

A Retrospective Analysis of Blood Component Utilization and Transfusion-Related Factors in a Diverse Patient Population.

A New Method for Screening Thalassemia Patients Using Mid-Infrared Spectroscopy.

The second reported case of a hemolytic transfusion reaction caused by anti-Sc2: a clinical diagnosis.

Beta-thalassemia and a missing malaria landscape.

[The Role of MiR-709 in Erythroid Development and Its Correlation with Multiple Hematological Diseases].

[Analysis of Gene Types and Clinical Characteristics of Thalassemia in Children in Nanchong Area].

[Screening Results of Thalassemia and Analysis of Rare Genotypes].

Closing the gap: do we need a framework for embedding equity in health technology assessment?

The Utility of HbA1c and Fructosamine in Evaluating the Glucose Tolerance in Adult Patients with Transfusion-Dependent Beta-Thalassemia.

[Beta thalassaemia: a surprising radiological image].

Clinical Applications of Ligand Traps Targeting Activin Type II Receptors.

Rising Star Engineering the Genome for Curative Futures.

Management of transfusion-dependent β-thalassaemia in the era of novel therapies: a prioritisation-based matrix for settings with limited resources.

Ovarian function compromise in pediatric beta-thalassemia major: a consequence of iron overload-induced mitochondrial and fibrotic damage.

Hb Yongning [β1 (NA1) Val→Leu; HBB:C.4G > C]: A Novel Hemoglobin Variant Causing Significant Interference in Common Glycated Hemoglobin Assays.

Therapeutic applications of CRISPR-Cas9 gene editing.

Epidemiological Profile of Haemoglobinopathies in Different Districts of West Bengal: A Retrospective Study.

Association of IL28B Polymorphisms With Hepatitis C Susceptibility in Southern Iran's β-Thalassemia Population: A Cross-Sectional Study.

Host Immunogenetics and Chronic HCV Infection Shape Atopic Risk in Pediatric Beta-Thalassemia: A Genotype-Phenotype Study.

Gene Therapy of Beta Hemoglobinopathies.

A Rare Combination of Hereditary Folate Malabsorption (SLC46A1 Gene Variant) and Beta-Thalassemia Trait.

Targeting LncRNAs with CRISPR/Cas9 for Kidney Therapeutics: A Review.

Haematological indices as screening tool in distinguishing beta thalassemia trait and iron deficiency anaemia: Insights from a tertiary hospital study.

Identification of RBM3 as a novel regulator of human fetal hemoglobin expression.

Nutritional deficiencies among adults with beta thalassemia major in Vietnam.

Carrier screening for multiple complex monogenic diseases using long-read sequencing: a population-based study of premarital couples in Shanghai.

Endocrine complications in patients with β-thalassemia major receiving iron-chelation therapy.

Analysis of Hematological Parameters in Relation to Genotypes in 497 Patients with Hemoglobin H Disease.

CRISPR editing of HPFH3 genotype induces γ-globin expression and reverses sickle cell disease and β-thalassemia phenotypes.

Novel LRF/ZBTB7A variants and known HbF-modulating SNPs in transfusion-dependent β-thalassemia.

Lowering cyclosporine trough concentration threshold effectively mitigates acute graft-versus-host disease in children with severe β-Thalassemia post hematopoietic stem cell transplantation.

p27Kip1 regulates γ-globin production.

Fragmented QRS duration as a marker of cardiac and hepatic iron overload: across-sectional study.

Alterations in iron status predict cardiac response to blood transfusion in β-thalassemia major.

Effects of fluconazole and voriconazole on cyclosporine levels and toxicity in allogenic hematopoietic stem cell transplant recipients: A comprehensive analysis.

Genosomes: An Introspection into Transfection, Future Perspectives and Applications.

Patra index and Mentzer index - A retrospective comparative study to differentiate Beta-Thalassemia Trait from iron deficiency anemia.

Frequency of Zinc Deficiency Among Thalassemia Major Patients: A Comparative Cross-Sectional Study.

Iron-associated central macular ganglion cell complex thinning and choroidal vascularity index elevation in transfusion-dependent β-thalassemia: potential OCT/OCTA biomarkers.

Performance of the automated DNA extraction with MagNA Pure 24 for further genetic testing for hemoglobinopathies with Globin StripAssays.

Family trios/quartets analysis based on the Newborn Genomic Atlas for Thalassemia project in Guangxi.

Identification of a Patient with Transfusion-Dependent β-Thalassemia Caused by Compound Heterozygous Mutations of HBB: C.84_85insC and Common Linked Intronic Variants in HBB.

A Cross-Sectional Study on Pain and Quality of Life of Adult Patients with Transfusion-Dependent Thalassemia in a Tertiary Hospital In Malaysia.

Liver Tissue Mapping in Transfusion-Dependent β-Thalassemia: Reproducibility and Clinical Insights from Multiparametric MRI.

Determinants of intertransfusion interval in children with transfusion-dependent thalassemia: a retrospective single-center cohort study in China.

Confounding Factors in the Diagnosis of Hereditary Spherocytosis and Gallstone Formation in Related Hemolytic Disorders From a Tertiary Care Center in North India.

[Application of the failure mode and effects analysis (FMEA) to the pharmaceutical process of Casgevy®, an ex vivo gene therapy medicinal product for beta-thalassemia].

Thalassemia and hypercoagulability.

Discovery of a Novel DNMT1 Inhibitor with Improved Efficacy in Treating β-Thalassemia.

Downregulation of ZBTB7A/LRF increases fetal hemoglobin expression in β0-thalassemia/hemoglobin E erythroid cells.

Trabecular bone score in the assessment of bone health in thalassemia major.

Rare variant hemoglobin Köln in Southern India-an underdiagnosed entity?

MAZ regulates fetal hemoglobin repression by activating MYB transcription.

The Application of Machine-Learning Algorithms for Multiclass Classification of Microcytic Anemia Revealed That a Minimum Required Number of Hematological Parameters Is Enough to Achieve High Diagnostic Accuracy.

A pilot study on the prevalence and patterns of haemoglobinopathies in Datia District, Madhya Pradesh, India.

Assessment of Adherence to Iron Chelation Therapy Among Thalassemia Patients in Palestine.

Epidemiology and economic burden of selected rare genetic diseases in Germany - a claims database study.

Base editing of β0-thalassemia mutations as a therapeutic strategy for severe β-hemoglobinopathies.

Metabolomic Investigation of Myelodysplastic Syndromes, Multiple Myeloma, and Homozygous β-Thalassemia.

Deep Vein Thrombosis in a Patient With Thalassemia Minor: A Case Report.

Safety and pharmacodynamics of the ferroportin inhibitor vamifeport in patients with non-transfusion-dependent β-thalassemia: results from a randomized phase 2a study.

Blood that was far from red: hypertriglyceridaema thalassaemia syndrome: case report.

Predicting the Double Heterozygotes of HbE and α-Thalassemia-1 (Southeast Asian Type) Using RapidMiner-Generated Hematologic Algorithm.

IFN-γ increases δ-globin gene expression through activation of the JAK/STAT pathway in erythroid cells.

Cord Blood-Based Neonatal Screening for Hemoglobinopathies in Northern Tunisia.

Genotypic and hematological profiling of thalassemia in reproductive-age and pediatric populations.

Impact of transferrin levels on iron accumulation in transfusion-dependent beta-thalassemia: A genotype-specific analysis.

Reproductive Considerations of Gene Therapies for Sickle Cell Disease and Beta-Thalassemia.

Molecular and structural characterization of a novel β-hemoglobinopathy caused by in Cis β-globin mutations in a Thai individual.

Multi-centric origins and gene flow shape the diversity of β-thalassemia mutations in Southern East Asia.

The development of an advanced lentiviral gene therapy for beta-thalassemia.

Biventricular and bia-trial strain by cardiac magnetic resonance in thalassaemia intermedia: patterns and correlates.

Case Report: identification of a novel 9.159-kb deletion in a Chinese α-thalassemia family using single molecule real-time technology sequencing.

Cardiovascular magnetic resonance derived pulmonary capillary wedge pressure in beta-thalassemia major: Clinical correlates and association with cardiac complications.

Quantitative MRI iron load assessment in β-thalassemia patients beyond the liver and heart: A systematic review.

The Masked Thalassemia: A Rare Case of a Patient with Normal HbA2 Levels, β-Thalassemia Pathogenic Variant (CD39 C>T), and a Novel δ-Globin Gene Deletion.

Administration of green tea polyphenols mitigates iron-overload-induced bone loss in a β-thalassemia mouse model.

Gene therapy for hemoglobinopathies: Clinical trial results and biology of hematopoietic stem cell and the bone marrow niche.

Predictive value of hepcidin and HIF1α protein levels for iron deposition in β-thalassemia.

Single-Position Peptide Clustering for Peptidomics Reveals Novel Disease Biomarkers and Dysregulated Proteolytic Characteristics.

A direct multiplex isothermal amplification-reverse dot blot hybridization system for β-thalassemia diagnosis.

Cellular and molecular targets in β-Thalassemia: advances in iron Regulation, Erythropoiesis, and Gene-Based therapies.

Placenta Percreta in the Absence of a Previous Uterine Scar.

Assessment of Hepcidin-25 and Iron Status Profiles in Pregnant Women With Thalassemia Minor.

Molecular identification and phenotypic study of a novel HBB: c.-23A>G mutation in the 5' untranslated region.

CRISPR/Cas12a-SERS biosensor based on sea urchin-like AuNPs for the detection of β-thalassemia mutant gene CD31.

Genetic Analysis and Clinical Relevance of HBA1:c.305T > C (Leu > Pro): A Novel Variant Linked to α-Thalassemia.

Accurate diagnosis of hemoglobinopathies with machine learning based on high-throughput proteomics.

Fasting Plasma Glucose Levels within the High Normal Range are Associated with a Significantly Increased Risk of Future Dysglycemia in Transfusion-Dependent β Thalassemia: A Decade-Long Multicenter Retrospective Analysis.

Post-Load Plasma Glucose Increase (PG-gap) as a Risk Factor for Developing Dysglycemia in Patients with Transfusion-Dependent β-Thalassemia (β-TDT): Retrospective Analysis over 8 Years.

[The Impact of Iron Overload on the Immune System in Patients with β-Thalassemia and Treatment Recommendations --Review].

[Analysis of Thalassemia Gene Variants in the Wuhan Region].

The cognitive profiles of people with β - Thalassemia across the life span: a systematic review.

Genotypic and phenotypic characterization of rare globin variants in Northern Guangxi, China.

Screening, genetic analysis, and clinical transfusion implications of thalassaemia and glucose-6-phosphate dehydrogenase deficiency in blood donors.

Assessment of β-Thalassemia Trait Occurrence in an Outpatient Sample from Southern Chile: A Retrospective Study.

Gene Therapies for Hemoglobinopathies: Efficacy, Cell Collection & Transfusion Support.

Genetic Analysis of a Patient with β-Thalassemia Major and Homozygous Hb Constant Spring in a Chinese Family.

B-Type Natriuretic Peptides Levels in Patients With Beta-Thalassemia Major and Correlations With Biomarkers: A Systematic Review and Meta-Analysis.

Beyond anemia: unraveling neutrophil defects and infection susceptibility in β-Thalassemia.